Ratings by Ladenburg Thalmann (Aydin Huseynov)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/18/2024 | Aileron Therapeutics Inc | ALRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2024 | Spruce Biosciences, Inc. | SPRB | Downgrade | Neutral (Buy) |
5.19 (0.70) |
-86.51% | Details | |
| 2/8/2024 | Biodexa Pharmaceuticals Plc. | BDRX | New Coverage | Buy (N/A) |
1.35 (0.75) |
-44.44% | Details | |
| 12/27/2023 | PMV Pharmaceuticals Inc. | PMVP | New Coverage | Buy (N/A) |
3.08 (1.69) |
-45.13% | Details | |
| 12/1/2023 | Aileron Therapeutics Inc | ALRN | Upgrade | Buy (Neutral) |
2.12 (4.93) |
132.55% | Details | |
| 10/10/2023 | Zura Bio Ltd. | ZURA | New Coverage | Buy (N/A) |
6.93 (3.31) |
-52.24% | Details | |
| 9/22/2023 | Coeptis Therapeutics Holdings, Inc. | COEP | New Coverage | Buy (N/A) |
0.94 (0.33) |
-64.89% | Details | |
| 7/10/2023 | Corvus Pharmaceuticals | CRVS | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2023 | Alterity Therapeutics | ATHE | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2023 | Corvus Pharmaceuticals | CRVS | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Acrivon Therapeutics Inc | ACRV | New Coverage | Buy (N/A) |
12.52 (9.50) |
-24.12% | Details | |
| 3/15/2023 | Bellicum Pharmaceuticals | BLCM | Downgrade | Neutral (Buy) |
0.86 (0.62) |
-27.91% | Details | |
| 3/10/2023 | Quoin Pharmaceuticals | QNRX | Downgrade | Neutral (Buy) |
0.53 (0.63) |
18.87% | Details | |
| 3/7/2023 | Adverum Biotechnologies | ADVM | New Coverage | Buy (N/A) |
0.77 (10.19) |
1223.38% | Details | |
| 2/22/2023 | Aileron Therapeutics Inc | ALRN | Downgrade | Neutral (Buy) |
1.46 (4.93) |
237.67% | Details | |
| 1/31/2023 | Palisade Bio Inc. | PALI | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Calithera Biosciences | CALA | Downgrade | Neutral (Buy) |
2.82 (0.37) |
-86.88% | Details | |
| 11/14/2022 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Quoin Pharmaceuticals | QNRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | NextCure Inc. | NXTC | Downgrade | Neutral (Buy) |
2.51 (1.44) |
-42.63% | Details | |
| 10/26/2022 | Capricor Therapeutics | CAPR | New Coverage | Buy (N/A) |
5.73 (5.04) |
-12.04% | Details | |
| 10/7/2022 | Corvus Pharmaceuticals | CRVS | New Coverage | Buy (N/A) |
0.88 (1.51) |
71.59% | Details | |
| 8/31/2022 | Satsuma Pharmaceuticals | STSA | New Coverage | Buy (N/A) |
6.32 (1.10) |
-82.59% | Details | |
| 8/23/2022 | Allarity Therapeutics Inc. | ALLR | Downgrade | Neutral (Buy) |
1.52 (1.37) |
-9.87% | Details | |
| 8/15/2022 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2022 | Alterity Therapeutics | ATHE | New Coverage | Buy (N/A) |
0.60 (2.33) |
288.33% | Details | |
| 7/27/2022 | Anebulo Pharmaceuticals | ANEB | New Coverage | Buy (N/A) |
3.05 (2.79) |
-8.52% | Details | |
| 7/13/2022 | Nuvectis Pharma | NVCT | New Coverage | Buy (N/A) |
12.69 (6.71) |
-47.12% | Details | |
| 6/13/2022 | Aileron Therapeutics Inc | ALRN | New Coverage | Buy (N/A) |
0.41 (4.93) |
1102.44% | Details | |
| 5/11/2022 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Quoin Pharmaceuticals | QNRX | New Coverage | Buy (N/A) |
0.81 (0.63) |
-22.22% | Details | |
| 5/2/2022 | Annovis Bio Inc. | ANVS | New Coverage | Buy (N/A) |
9.44 (12.74) |
34.96% | Details | |
| 4/22/2022 | Cognition Therapeutics | CGTX | New Coverage | Buy (N/A) |
3.10 (1.99) |
-35.81% | Details | |
| 4/4/2022 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Calithera Biosciences | CALA | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2022 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
1.44 (1.48) |
2.78% | Details | |
| 3/8/2022 | Spruce Biosciences, Inc. | SPRB | New Coverage | Buy (N/A) |
1.88 (0.70) |
-62.77% | Details | |
| 3/1/2022 | NextCure Inc. | NXTC | New Coverage | Buy (N/A) |
4.90 (1.44) |
-70.61% | Details | |
| 2/16/2022 | Bellicum Pharmaceuticals | BLCM | New Coverage | Buy (N/A) |
1.45 (0.62) |
-57.24% | Details | |
| 2/7/2022 | SELLAS Life Sciences Group | SLS | New Coverage | Buy (N/A) |
5.41 (1.54) |
-71.53% | Details | |
| 2/2/2022 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
1.23 (6.35) |
416.26% | Details | |
| 1/31/2022 | Calithera Biosciences | CALA | New Coverage | Buy (N/A) |
0.42 (0.37) |
-11.9% | Details |
